Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorJean, Francois
dc.contributor.authorArsandaux, Julie
dc.contributor.authorMontagni, Ilaria
dc.contributor.authorCollet, Ophélie
dc.contributor.authorFatséas, Mélina
dc.contributor.authorAuriacombe, Marc
dc.contributor.authorRamos Quiroga, José Antonio
dc.date.accessioned2022-08-12T06:31:20Z
dc.date.available2022-08-12T06:31:20Z
dc.date.issued2022-03-29
dc.identifier.citationJean FAM, Arsandaux J, Montagni I, Collet O, Fatséas M, Auriacombe M, et al. Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort. Eur Psychiatry. 2022 Mar 29;65(1):1–18.
dc.identifier.issn1778-3585
dc.identifier.urihttp://hdl.handle.net/11351/7995
dc.descriptionADHD; Cannabis; Students
dc.description.abstractBackground Cannabis use in university students is associated with academic achievement failure and health issues. The objective of the study was to evaluate the association between attention deficit hyperactivity disorder (ADHD) symptoms and cannabis use after 1 year among students according to previous cannabis use. Methods Students in France were recruited from February 2013 to July 2020 in the i-Share cohort. 4,270 participants were included (2,135 who never used cannabis at inclusion and 2,135 who did). The Adult ADHD Self-Report Scale (ASRS) was used to assess ADHD symptoms at inclusion. Cannabis use frequency was evaluated 1 year after inclusion. Multinomial regressions were conducted to assess the association between inclusion ADHD symptoms and cannabis use after 1 year. Results Increase in ASRS scores was linked with a greater probability to use cannabis after 1 year and to have a higher cannabis use frequency (once a year—once a month adjusted odds ratio [OR]: 1.24 (1.15–1.34), more than once a month adjusted OR: 1.43 (1.27–1.61)). Among participants who never used cannabis at inclusion, this association disappeared (once a year—once a month adjusted OR: 1.15 (0.95–1.39), more than once a month adjusted OR: 1.16 (0.67–2)) but remained in participants who ever used cannabis at inclusion (once a year—once a month adjusted OR: 1.17 (1.06–1.29), more than once a month adjusted OR: 1.35 (1.18–1.55)). Conclusions High levels of ADHD symptoms in students could lead to continued cannabis use rather than new initiations.
dc.language.isoeng
dc.publisherCambridge University Press
dc.relation.ispartofseriesEuropean Psychiatry;65(1)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectEstudiants
dc.subjectTrastorn per dèficit d'atenció amb hiperactivitat
dc.subjectAbús de substàncies
dc.subject.meshAttention Deficit Disorder with Hyperactivity
dc.subject.meshMarijuana Abuse
dc.subject.meshStudents
dc.titleAttention deficit hyperactivity disorder symptoms and cannabis use after 1 year among students of the i-Share cohort
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1192/j.eurpsy.2022.14
dc.subject.decstrastornos de déficit de atención con hiperactividad
dc.subject.decsabuso de marihuana
dc.subject.decsestudiantes
dc.relation.publishversionhttp://dx.doi.org/10.1192/j.eurpsy.2022.14
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Jean FAM] Department of Psychiatry, Dr Jean Eric Techer Hospital, Calais, France. University of Bordeaux, Faculty of Medicine, Bordeaux, France. Bordeaux Population Health Research Center, National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale—INSERM), Bordeaux, France. [Arsandaux J, Montagni I, Collet O] University of Bordeaux, Faculty of Medicine, Bordeaux, France. Bordeaux Population Health Research Center, National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale—INSERM), Bordeaux, France. [Fatséas M] University of Bordeaux, Faculty of Medicine, Bordeaux, France. Charles Perrens Hospital, Bordeaux, France. Centre Hospitalier Universitaire de Bordeaux (CHU de Bordeaux), Bordeaux, France. National Center for Scientific Research (Centre national de la recherche scientifique—CNRS), Institut de Neurosciences Cognitives et Intégratives d’Aquitaine (INCIA), Bordeaux, France. [Auriacombe M] University of Bordeaux, Faculty of Medicine, Bordeaux, France. Charles Perrens Hospital, Bordeaux, France. Centre Hospitalier Universitaire de Bordeaux (CHU de Bordeaux), Bordeaux, France. National Center for Scientific Research (Centre national de la recherche scientifique—CNRS), Addiction Team/SANPSY, Bordeaux, France. [Ramos-Quiroga JA] Grup de Recerca en Psiquiatria, Salut Mental i Addiccions, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Psiquiatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Barcelona, Spain. Departament de Psiquiatria i Medicina Legal, Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid35348052
dc.identifier.wos000786370300001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record